Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Gastrointestinal 2 Gynecologic 1 Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 46 Specimen Handling 39 enzalutamide 32 Nivolumab 30 pembrolizumab 29 Gemcitabine 25 Docetaxel 24 apalutamide 20 Prednisone 20 Biopsy 20 Androgen Antagonists 18 Abiraterone Acetate 18 Cisplatin 15 cabozantinib 14 abiraterone 14 Radiotherapy 14 darolutamide 13 enfortumab vedotin 12 Ipilimumab 12 Radiosurgery 11 Radiation 11 Pluvicto 11 belzutifan 10 Mitomycin 10 erdafitinib 9 atezolizumab 9 X-Rays 9 olaparib 8 durvalumab 8 cabazitaxel 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Testing × Genitourinary × 30 days × Clear all

NCT06632977 2026-06-02

PREDICT

Alliance for Clinical Trials in Oncology

Phase 2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡